This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Under-$10 Stocks Due to Surge

Astex Pharmaceuticals

One under-$10 stock that's setting up to break out here is Astex Pharmaceuticals (ASTX), which is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology and hematology. This stock has been on fire during the last six months, with shares soaring higher by 38%.

This company received some bullish news this morning, when a case report published online by Pediatrics said patients in a trial of Astex's drug Dacogen achieved complete remission.

If you take a look at the chart for Astex Pharmaceuticals, you'll notice that this stock has uptrending modestly for the past two months, with shares moving higher from a low of $2.15 to its intraday high of $3.06 a share. During that uptrend, shares of ASTX have been mostly making higher lows and higher highs, which is bullish technical price action. That move has now pushed ASTX within range of triggering a near-term breakout trade.

Traders should now look for long-biased trades in ASTX if it manages to break out above some near-term overhead resistance levels at $3.03 to $3.20 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 523,056 shares. If that breakout hits soon, then ASTX will set up to re-test or possibly take out its next major overhead resistance levels at $3.40 to $3.49 a share.

Any move above $3.49 will then push ASTX into new 52-week high territory, which is bullish technical price action. Some possible upside targets off any run over $3.49 a share are $4 to $4.50 a share and possibly even $5 a share.

Traders can look to buy ASTX off any weakness as long as it's trending above some near-term support at its 50-day moving average of $2.60 a share. I would use a stop that sits just below that level. You can also buy off strength once ASTX takes out those breakout levels with volume and then simply use a stop that sits just below $2.88 a share.
2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ASTX $0.00 0.00%
ENVI $0.00 0.00%
ACW $1.59 -1.90%
DRD $5.45 0.74%
OSIR $5.76 2.70%


Chart of I:DJI
DOW 17,888.04 +114.40 0.64%
S&P 500 2,081.59 +16.29 0.79%
NASDAQ 4,818.61 +43.2520 0.91%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs